Angela Hwang
CIK 1725474 · President, Global Biopharma · last filed 2026-05-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.24M
Companies
2
Total Filings
25
Lifetime Open-Market Net
-$1.30M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 3 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-01 | PFE | Mixed | +7,387 | -$91.3K | EDGAR |
| 2019-02-26 | PFE | Tax (F) | −1,565 | -$67.4K | EDGAR |
| 2018-02-28 | PFE | Mixed | +2,841 | -$54.3K | EDGAR |
| 2018-02-27 | PFE | Tax (F) | −976 | -$36.2K | EDGAR |
| 2018-02-23 | PFE | Grant (A) | — | $0 | EDGAR |
Showing 21–25 of 25
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.